| TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure. | |
| | |
MedLine Citation:
|
PMID: 18280594 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Tumor necrosis factor alpha (TNFalpha) has been shown to be a prognostic marker in heart failure, but recent clinical trials using TNFalpha antagonists in patients with severe heart failure have been disappointing. Hypertension is one of most common causes to chronic heart failure in humans. HYPOTHESIS: Suppression of a single cytokine in CHF is not an effective treatment strategy because it leads to the upregulation of other proinflammatory cytokines. OBJECTIVES: The aim of the present study was to investigate the effect of chronic treatment with a TNFalpha antagonist in a rat model of the early stage of heart failure due to hypertension. METHODS: Spontaneously hypertensive rats (SHR, n=30) and healthy Wistar Kyoto rats (WKY, n=30) were treated with either the TNFalpha antagonist etanercept or placebo for 12 weeks. At the end of the study, the rats were 26 weeks old and indices of cardiac structure, function and cytokines were analyzed. RESULTS: SHR displayed early stage of heart failure as shown by increased heart weight/body weight ratio and relative wall thickness by echocardiography, downregulated myocardial beta(1)-adrenoceptor, and upregulated myocardial brain natriuretic peptide and interleukin-6 (IL6). Chronic treatment with etanercept in SHR resulted in decreased relative wall thickness but also increased cardiac reserve and higher blood pressure. In addition, IL6 was further upregulated compared with placebo treatment. CONCLUSION: Chronic treatment with etanercept in SHR resulted in favorable cardiac remodeling, but also had a positive inotropic effect and was associated with an upregulation of IL6. These findings indicate that chronic treatment with TNFalpha antagonists is not an effective treatment strategy and may aggravate heart failure in the long term. |
| | |
Authors:
|
Espen Haugen; Margareta Scharin Täng; Azra Isic; Bert Andersson; Michael Fu |
Related Documents
:
|
17709654 - Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesart... 22284924 - Polymorphic ventricular tachycardia in a patient with herpes encephalitis. 15834444 - Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone c... 7116254 - Protection of ischemic myocardium: the roles of nutrition and myocardial glycogen. 83634 - Overdrive pacing for supraventricular tachycardia: a review of theoretical implications... 7081014 - Noninvasive detection and localization of coronary stenoses in patients: comparison of ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-02-15 |
Journal Detail:
|
Title: International journal of cardiology Volume: 130 ISSN: 1874-1754 ISO Abbreviation: Int. J. Cardiol. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-10-22 Completed Date: 2009-01-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 64-8 Citation Subset: IM |
Affiliation:
|
Department of Molecular & Clinical Medicine and Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Sweden. Espen.haugen@wlab.gu.se |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Inflammatory Agents, Non-Steroidal / pharmacology* Chronic Disease Disease Models, Animal Heart Failure / etiology, physiopathology* Hypertension / complications Immunoglobulin G / pharmacology* Interleukin-6 / biosynthesis* Male Rats Rats, Inbred SHR Receptors, Tumor Necrosis Factor Tumor Necrosis Factor-alpha / antagonists & inhibitors* Up-Regulation / drug effects Ventricular Remodeling / drug effects* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Immunoglobulin G; 0/Interleukin-6; 0/Receptors, Tumor Necrosis Factor; 0/Tumor Necrosis Factor-alpha; 185243-69-0/TNFR-Fc fusion protein |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Consummatory behavior and metabolic indicators after central ghrelin injections in rats.
Next Document: Capsaicin, arterial hypertensive crisis and acute myocardial infarction associated with high levels ...